Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 48.5156.2082.53135.57-72.44

What is the latest EBIT Growth ratio of KILITCH DRUGS (INDIA) ?

The latest EBIT Growth ratio of KILITCH DRUGS (INDIA) is 48.51 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202448.51
Mar202356.20
Mar202282.53
Mar2021135.57
Mar2020-72.44

How is EBIT Growth of KILITCH DRUGS (INDIA) Trending?

Years EBIT Growth % Change
Mar2024 48.51
-13.68
Mar2023 56.2
-31.90
Mar2022 82.53
-39.12
Mar2021 135.57
Positive
Mar2020 -72.44 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare EBIT Growth ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹653.1 Cr 4.1% 1.7% 14.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,872.0 Cr 0.6% 3.6% -12.5% Stock Analytics
DIVIS LABORATORIES ₹175,706.0 Cr 1% 9.4% 8% Stock Analytics
CIPLA ₹127,449.0 Cr 0.9% 1.2% -0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,125.0 Cr 1.7% 1% 1% Stock Analytics
DR REDDYS LABORATORIES ₹104,827.0 Cr -0.5% -4.2% -6.3% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

4.1%

1.7%

14.5%

SENSEX

1.8%

1.9%

2.4%


You may also like the below Video Courses